Navigation Links
Pharmaceutical Product Marketing: Launching Drugs That Outperform the Competition
Date:10/5/2007

CHAPEL HILL, N.C., Oct. 5 /PRNewswire/ -- While Megabrands are more and more an exception today and many companies invest in specialty therapeutic areas, the underlying principles of how to develop, market, sell and manage a blockbuster drug that will outperform the competition are still the same -- and are still sought after by pharmaceutical and biotech companies alike.

Best Practices, LLC's leading benchmarking report "Launching Pharmaceutical Megabrands: Best Practices in Marketing Blockbusters" delivers the critical building blocks essential for new product management pre and post launch. What separates industry leaders from other pharmaceutical executives is vital knowledge of when in the process to start building and where to focus resources during development - the report provides those answers.

For a complimentary download of research study excerpts, please visit http://www3.best-in-class.com/rr862.htm.

In the benchmarking report, research analysts compile compelling metrics, best practices and lessons learned from survey responses and in-depth interviews with 24 top executives at companies such as Pfizer, Merck, Sanofi-Aventis, GlaxoSmithKline, Eli Lilly, Amgen, Boehringer-Ingelheim and Novartis.

The myriad of insights gleaned from interviewees on such topics as marketing support investment and expense patterns for high potential products will inform all marketing and branding decision-makers throughout the drug development cycle.

To learn more about the winning tactics, proven investment patterns and other tried-and-true strategies for optimizing drug launch success, see the complimentary report summary at http://www3.best-in-class.com/rr862.htm.

To drill down on the countless metrics and best practices presented in this report contact our Solution Specialists at (919) 403-0251 or bestpractices@best-in-class.com.

If you have questions regarding your own product launch, need a health check for your marketing investments, or would like to discuss how Best Practices, LLC can support your drug marketing, launch or lifecycle initiatives, please contact Cameron Tew at 919-767-9246 or ctew@best-in-class.com.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 15 years; our clients include 43 out of the top 50 pharmaceutical companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. South Africa Wins landmark case against pharmaceutical giants
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Setting up a new pharmaceutical industry in India
5. Medicis Pharmaceutical company enters pediatric market
6. Supply of Radiopharmaceuticals Hampered by Attacks
7. Pharmaceutical companies are targeting patients
8. FDA approves Watson Pharmaceuticals Oxytrol patch
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
11. Pharmaceutical industries grant for R&D to be monitored
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2017)... , ... April 22, 2017 ... ... of Eastern Pennsylvania has named PROSHRED® Security of Philadelphia its “Woman-Owned ... PROSHRED® Philadelphia specializes in providing information destruction , recycling, and ...
(Date:4/22/2017)... (PRWEB) , ... April 22, 2017 , ... ... to his role as Vice President of Sales and Business Development at OAKWORKS, ... GPO/IDN business partner engagements, business development, and strategic planning for the company. ...
(Date:4/21/2017)... , ... April 21, 2017 , ... An April 10 ... a pair of ancient teeth, which reveal a great deal about prehistoric ice-age dental ... sharp stone may have been used to remove decayed dental matter, and that teeth ...
(Date:4/21/2017)... Beach, FL (PRWEB) , ... April 21, 2017 , ... The staff at Palm Beach ... will be taking part in the 2017 London Marathon. Set to take place on April ... charitable organizations. This year, Dr. Schwartz will run as part of team EMPOWER, raising money ...
(Date:4/21/2017)... ... 2017 , ... Chicago plastic surgeon, Dr. Anil R. Shah, MD , ... benign bony lump located on the forehead usually attributed to a facial fracture. Their ... pain. Dr. Shah has discovered an approach that is minimally invasive. He is an ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
(Date:4/20/2017)... April 20, 2017 Eyevensys, a ... first non-viral gene expression technology that enables the safe, ... to address a wide range of ophthalmic diseases, announces ... Healthcare products Regulatory Agency (MHRA) to advance its technology ... ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), ... Forecasts, 2014 - 2025" report to their offering. ... The Latin American pharmaceutical ... billion by 2025 Low drug registration cost in ...
Breaking Medicine Technology: